In vitro activities of daptomycin-, vancomycin-, and teicoplanin-loaded polymethylmethacrylate against methicillin-susceptible, methicillin-resistant, and vancomycin-intermediate strains of Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 12, 2011, Pages 5480-5484

  Chang, Yuhan ^a,b   Chen, Wen Chien ^a,b   Hsieh, Pang Hsin ^a,b   Chen, Dave W ^a,b   Lee, Mel S ^a,b   Shih, Hsin Nung ^a,b   Ueng, Steve W N ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CEMENT; DAPTOMYCIN; POLY(METHYL METHACRYLATE); TEICOPLANIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; ASSAY; BROTH ELUTION ASSAY; CONTROLLED STUDY; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BONE CEMENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DAPTOMYCIN; HUMANS; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; POLYMETHYL METHACRYLATE; STAPHYLOCOCCUS AUREUS; TEICOPLANIN; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 81555200474     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05312-11     Document Type: Article

References (21)

1. Appelbaum, P. C. 2006. MRSA - the tip of the iceberg. Clin. Microbiol. Infect. 12(Suppl. 2):3-10. (Pubitemid 43355765)
2. Bowker, K. E., A. R. Noel, and A. P. MacGowan. 2009. Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection. J. Antimicrob. Chemother. 64: 1044-1051.
3. Carpenter, C. F., and H. F. Chambers. 2004. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin. Infect. Dis. 38:994-1000. (Pubitemid 38457208)
4. Chang, S., et al. 2003. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med. 348:1342-1347. (Pubitemid 36384101)
5. Chiu, F. Y., C. M. Chen, C. F. Lin, and W. H. Lo. 2002. Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees. J. Bone Joint Surg. Am. 84-A:759-762.
6. Davis, J. S. 2005. Management of bone and joint infections due to Staphylococcus aureus. Intern. Med. J. 35 s. 2:S79-96.
7. Fuchs, P. C., A. L. Barry, and S. D. Brown. 2000. Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests. Diagn. Microbiol. Infect. Dis. 38:51-58.
8. Goldenberg, D. L. 1998. Septic arthritis. Lancet 351:197-202. (Pubitemid 28037017)
9. Hanssen, A. D. 2005. Local antibiotic delivery vehicles in the treatment of musculoskeletal infection. Clin. Orthop. Relat. Res. 437:91-96. (Pubitemid 41099072)
10. Hiramatsu, K., et al. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136. (Pubitemid 27341646)
11. Howden, B. P., P. D. Johnson, P. G. Charles, and M. L. Grayson. 2004. Failure of vancomycin for treatment of methicillin-resistant Staphylococcus aureus infections. Clin. Infect. Dis. 39:1544.
12. Hsieh, P. H., Y. H. Chang, S. H. Chen, S. W. Ueng, and C. H. Shih. 2006. High concentration and bioactivity of vancomycin and aztreonam eluted from Simplex cement spacers in two-stage revision of infected hip implants: a study of 46 patients at an average follow-up of 107 days. J. Orthop. Res. 24:1615-1621.
13. Jiranek, W. A., A. D. Hanssen, and A. S. Greenwald. 2006. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J. Bone Joint Surg. Am. 88:2487-2500. (Pubitemid 44713839)
14. Kuechle, D. K., G. C. Landon, D. M. Musher, and P. C. Noble. 1991. Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement. Clin. Orthop. Relat. Res. 264:302-308.
15. Moise-Broder, P. A., A. Forrest, M. C. Birmingham, and J. J. Schentag. 2004. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin. Pharmacokinet. 43:925-942. (Pubitemid 39447034)
16. Murray, W. R. 1984. Use of antibiotic-containing bone cement. Clin. Orthop. Relat. Res. 190:89-95. (Pubitemid 15223468)
17. Penner, M. J., B. A. Masri, and C. P. Duncan. 1996. Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J. Arthroplasty. 11:939-944.
18. Rouse, M. S., et al. 2006. Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis. J. Antimicrob. Chemother. 57:301-305. (Pubitemid 43160173)
19. Sakoulas, G., et al. 2004. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J. Clin. Microbiol. 42:2398-2402. (Pubitemid 38747480)
20. Tuzuner, T., et al. 2006. In vivo evaluation of teicoplanin- and calcium sulfate-loaded PMMA bone cement in preventing implant-related osteomyelitis in rats. J. Chemother. 18:628-633. (Pubitemid 46045393)
21. Zalavras, C. G., M. J. Patzakis, and P. Holtom. 2004. Local antibiotic therapy in the treatment of open fractures and osteomyelitis. Clin. Orthop. Relat. Res. 427:86-93. (Pubitemid 39362836)